205 related articles for article (PubMed ID: 23867757)
1. Zoledronic acid inhibits human osteoblast activities.
Basso FG; Silveira Turrioni AP; Hebling J; de Souza Costa CA
Gerontology; 2013; 59(6):534-41. PubMed ID: 23867757
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts.
Basso FG; Pansani TN; de Oliveira CF; Turrioni AP; Soares DG; Hebling J; Costa CA
Braz Dent J; 2013; 24(6):551-8. PubMed ID: 24474348
[TBL] [Abstract][Full Text] [Related]
4. Effects of zoledronic acid on odontoblast-like cells.
Basso FG; Turrioni AP; Hebling J; de Souza Costa CA
Arch Oral Biol; 2013 May; 58(5):467-73. PubMed ID: 23092609
[TBL] [Abstract][Full Text] [Related]
5. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
Schindeler A; Little DG
Biochem Biophys Res Commun; 2005 Dec; 338(2):710-6. PubMed ID: 16243296
[TBL] [Abstract][Full Text] [Related]
6. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells.
Açil Y; Möller B; Niehoff P; Rachko K; Gassling V; Wiltfang J; Simon MJ
J Craniomaxillofac Surg; 2012 Dec; 40(8):e229-35. PubMed ID: 22082730
[TBL] [Abstract][Full Text] [Related]
7. Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid.
Basso FG; Turrioni AP; Soares DG; Bagnato VS; Hebling J; de Souza Costa CA
Support Care Cancer; 2014 Oct; 22(10):2741-8. PubMed ID: 24801347
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
10. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
[TBL] [Abstract][Full Text] [Related]
11. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
12. The effects of bisphosphonates on osteoblasts in vitro.
Naidu A; Dechow PC; Spears R; Wright JM; Kessler HP; Opperman LA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):5-13. PubMed ID: 18504149
[TBL] [Abstract][Full Text] [Related]
13. Expression of extracellular matrix proteins in human periodontal ligament cells during mineralization in vitro.
Nohutcu RM; McCauley LK; Koh AJ; Somerman MJ
J Periodontol; 1997 Apr; 68(4):320-7. PubMed ID: 9150036
[TBL] [Abstract][Full Text] [Related]
14. Cryopreservation of osteoblast-like cells: viability and differentiation with replacement of fetal bovine serum in vitro.
Reuther T; Kettmann C; Scheer M; Kochel M; Iida S; Kubler AC
Cells Tissues Organs; 2006; 183(1):32-40. PubMed ID: 16974093
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
Zara S; De Colli M; di Giacomo V; Zizzari VL; Di Nisio C; Di Tore U; Salini V; Gallorini M; Tetè S; Cataldi A
Clin Oral Investig; 2015 Apr; 19(3):601-11. PubMed ID: 25055744
[TBL] [Abstract][Full Text] [Related]
16. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
[TBL] [Abstract][Full Text] [Related]
17. Effects of hydrogen peroxide (H2O2) on alkaline phosphatase activity and matrix mineralization of odontoblast and osteoblast cell lines.
Lee DH; Lim BS; Lee YK; Yang HC
Cell Biol Toxicol; 2006 Jan; 22(1):39-46. PubMed ID: 16463018
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
Huang X; Huang S; Guo F; Xu F; Cheng P; Ye Y; Dong Y; Xiang W; Chen A
Mol Med Rep; 2016 Jan; 13(1):613-22. PubMed ID: 26648136
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotective effects of melatonin on zoledronic acid-treated human osteoblasts.
Camacho-Alonso F; Urrutia-Rodríguez I; Oñate-Cabrerizo D; Oñate-Sánchez RE; Rodríguez-Lozano FJ
J Craniomaxillofac Surg; 2017 Aug; 45(8):1251-1257. PubMed ID: 28552199
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
